Skip to main content
| News

Both Basel cantons are first class borrowers

09.11.2020

Standard & Poor’s has awarded the canton of Basel-City its top rating of AAA. The rating agency anticipates that Basel will manage the crisis better than the rest of Switzerland and Europe thanks to an established Life Sciences sector. Basel-Landschaft has also maintained its impressive rating of AA+.

The rating agency Standard & Poor’s has confirmed its top rating of AAA for the canton of Basel-City. The agency expects an excellent budgetary performance for 2021. Any deficits generated due to the coronavirus crisis are likely to be small and temporary, the agency writes in its report. Switzerland as a whole is likely to recover from the crisis more quickly than its neighboring countries, and Basel-City even faster than the rest of the country.

From the perspective of Standard & Poor’s, Basel-City is an “economic powerhouse”, with the canton’s Life Sciences sector responsible for its strong economic position. Some of the largest companies in this industry have their headquarters located in the region. At the same time, these firms have diversified within their industries and reduced their dependency on individual sub-sectors and products. In addition, the numerous companies in the canton attract commuters from both Switzerland and abroad.

As a net contributor within the framework of the federal financial equalization system in Switzerland, the canton is now also benefitting from a reduction in payments to other cantons. This development is the result of reforms to corporate taxation that took effect from the start of 2020. This will lead to extraordinary additional income being posted for both 2020 and 2021.

Standard & Poor’s is of the view that only one conceivable risk now exists to the canton’s finances: its stake in the Cantonal Bank of Basel and the state guarantee for the majority of the deposits. At the moment, however, it is unlikely that this could negatively impact the cantonal budget. The cantonal finance department points out in a press release that, of the cantons directly assessed by Standard & Poor’s, only the cantons of Zurich and Vaud have also been awarded the top rating of AAA.

The rating agency has also assessed the financial situation of the canton of Basel-Landschaft. According to a press release issued by the cantonal finance department of this neighboring canton, its impressive rating of AA+ has been maintained with a stable outlook. It also underlines the fact that the economy of the region is strong, with a stable and predictable state framework and positive annual financial statements. Standard & Poor’s is anticipating that the canton of Basel-Landschaft will also quickly cope with the consequences of the coronavirus crisis, according to the press release.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

BeiGene opens European headquarters in Basel
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

BeiGene opens European headquarters in Basel

BeiGene has opened its new European headquarters in Basel. The global biotech specializing in innovative cancer treatments intends to build...

Read More
The 25 Best AI Courses in the Basel Area, Germany and France
Advanced Manufacturing/AI, Basel Area Business & Innovation, Innovation

The 25 Best AI Courses in the Basel Area, Germany and France

Artificial Intelligence (AI) offers numerous possible applications. But how, where and regarding which focal points can you get further training...

Read More
Engimmune Therapeutics banks 15.5 million Swiss francs
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Engimmune Therapeutics banks 15.5 million Swiss francs

Engimmune Therapeutics will now be in a position to drive forward its innovative platforms for the development of T-cell therapies...

Read More
Bionter receives 3 million US dollars in investments
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Bionter receives 3 million US dollars in investments

Bionter AG has received 3 million US dollars in a seed funding round. These funds will enable Bionter to bring...

Read More
Resistell seeking to further develop test to combat antibiotic resistance
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Resistell seeking to further develop test to combat antibiotic resistance

The startup Resistell has launched a study looking into the applicability of a test against antibiotic resistances that is being...

Read More
Biotech startup Cimeio receives 46 million Swiss francs for cell therapy
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Biotech startup Cimeio receives 46 million Swiss francs for cell therapy

Cimeio Therapeutics from Basel has received initial financing amounting to 46 million Swiss francs from Versant Ventures. The startup is...

Read More
1 2 3 55

Do you have a question? We'd like to hear from you.